BRD3
Bromodomain-containing protein 3
Also known as: BRD3_HUMAN, KIAA0043, ORFX, RING3L
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15059
- Gene
- BRD3
- Ensembl
- ENSG00000169925
- Chromosome
- 9
- Canonical length
- 726 aa
- Protein class
- Cancer-related genes, Disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene was identified based on its homology to the gene encoding the RING3 protein, a serine/threonine kinase. The gene localizes to 9q34, a region which contains several major histocompatibility complex (MHC) genes. The function of the encoded protein is not known. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
726 residues, UniProt reviewed canonical sequence.
>Q15059|BRD3
1 MSTATTVAPA GIPATPGPVN PPPPEVSNPS KPGRKTNQLQ YMQNVVVKTL WKHQFAWPFY
61 QPVDAIKLNL PDYHKIIKNP MDMGTIKKRL ENNYYWSASE CMQDFNTMFT NCYIYNKPTD
121 DIVLMAQALE KIFLQKVAQM PQEEVELLPP APKGKGRKPA AGAQSAGTQQ VAAVSSVSPA
181 TPFQSVPPTV SQTPVIAATP VPTITANVTS VPVPPAAAPP PPATPIVPVV PPTPPVVKKK
241 GVKRKADTTT PTTSAITASR SESPPPLSDP KQAKVVARRE SGGRPIKPPK KDLEDGEVPQ
301 HAGKKGKLSE HLRYCDSILR EMLSKKHAAY AWPFYKPVDA EALELHDYHD IIKHPMDLST
361 VKRKMDGREY PDAQGFAADV RLMFSNCYKY NPPDHEVVAM ARKLQDVFEM RFAKMPDEPV
421 EAPALPAPAA PMVSKGAESS RSSEESSSDS GSSDSEEERA TRLAELQEQL KAVHEQLAAL
481 SQAPVNKPKK KKEKKEKEKK KKDKEKEKEK HKVKAEEEKK AKVAPPAKQA QQKKAPAKKA
541 NSTTTAGRQL KKGGKQASAS YDSEEEEEGL PMSYDEKRQL SLDINRLPGE KLGRVVHIIQ
601 SREPSLRDSN PDEIEIDFET LKPTTLRELE RYVKSCLQKK QRKPFSASGK KQAAKSKEEL
661 AQEKKKELEK RLQDVSGQLS SSKKPARKEK PGSAPSGGPS RLSSSSSSES GSSSSSGSSS
721 DSSDSELocalizationUniProt · AlphaFold · HPA
Whether an antibody against BRD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 18 nTPM
- colon: 15 nTPM
- endometrium: 14 nTPM
- cerebellum: 13 nTPM
- thymus: 13 nTPM
- cervix: 12 nTPM
Single-cell type
- platelets: 239 nCPM
- erythrocyte progenitors: 77 nCPM
- differentiating spermatogonia: 75 nCPM
- peritubular myoid cells: 73 nCPM
- leydig cells: 67 nCPM
- epididymal principal cells: 65 nCPM
Immune cell
- plasmacytoid DC: 17 nTPM
- NK-cell: 16 nTPM
- eosinophil: 16 nTPM
- neutrophil: 15 nTPM
- classical monocyte: 13 nTPM
- myeloid DC: 13 nTPM
Brain region
- white matter: 45 nTPM
- basal ganglia: 43 nTPM
- hypothalamus: 42 nTPM
- amygdala: 42 nTPM
- cerebral cortex: 42 nTPM
- medulla oblongata: 42 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.32
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 2.64
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin remodeling
- endodermal cell differentiation
- positive regulation of transcription by RNA polymerase II
- protein localization to chromatin
- regulation of transcription by RNA polymerase II
Molecular functions
- chromatin binding
- histone binding
- histone H3K9me2/3 reader activity
- histone reader activity
- lncRNA binding
- molecular condensate scaffold activity
- protein serine/threonine kinase activity
- histone H3K18cr reader activity
- histone H3K27cr reader activity
- histone H3K9cr reader activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BRD3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BRD3 as an antibody target. Whether an autoantibody or antibody against BRD3 could matter depends on whether native BRD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BRD3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BRD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...